Therapeutic strategies for anti-neoplastic activity in ovarian carcinomas
- Prosjektnummer
- 911852
- Ansvarlig person
- Katharina Bischof
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 2. Aetiology, 4. Detection and Diagnosis
Our research group has been co-operating with Gynkreftforeningen over the last years. As Gynkreftforeningen is a nationwide patient organization for women who have (had) gynecologic cancer, we believe that an interaction will bring important aspects into the ongoing subproject in our research group. Already during the planning phase, relevant projects have been presented to and discussed with representatives from this organization. And they have agreed on behalf of the Gynkreftforeningen to act as advisors throughout the project period.
Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study.
Int J Epidemiol 2018 04 01;47(2):450-459.
PMID: 29186515
High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.
BMC Cancer 2018 Jun 25;18(1):684. Epub 2018 jun 25
PMID: 29940909 - Inngår i doktorgradsavhandlingen
The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.
PLoS One 2016;11(6):e0158208. Epub 2016 jun 28
PMID: 27352023 - Inngår i doktorgradsavhandlingen
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
Hum Genet 2016 Jul;135(7):741-56. Epub 2016 apr 13
PMID: 27075448
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Hum Mol Genet 2015 Oct 15;24(20):5955-64. Epub 2015 jul 30
PMID: 26231222
- Line Bjørge Hovedveileder
- Katharina Bischof Ph.d.-kandidat
- Stian Knappskog Medveileder
- Bjørn Tore Gjertsen Medveileder
- Emmet Mc Cormack Medveileder
- Emmet Martin Mc Cormack Medveileder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest